The total prevalence rate of tracheooesophageal fistula and oesophageal atresia in 15 
Tracheo-oesophageal fistula and oesophageal atresia (TOFA) is a group of congenital anomalies occurring by the sixth week of embryonic life.' Most forms are well recognised at birth through their symptomatology and may be suspected prenatally because of maternal polyhydramnios.
There are various reports indicating environmental and/or genetic factors in the aetiology of the malformation,'4 and probable aetiological heterogeneity of the condition. There is a need for more epidemiological data to clarify these issues and to form a background for analytic studies.
EUROCAT is a concerted action of the European Community for the surveillance of congenital anomalies. Regional registries cover geographically defined populations in Europe. This descriptive registry based study aims to provide an epidemiological overview of TOFA in Europe for a recent time period . Although more than 1-5 million births were surveyed in the time period considered, this is nevertheless not sufficient for a detailed analysis of some variables of interest, such as twins, siblings, and individual associated malforma- tions. The study has therefore been carried out in collaboration with the International Clearinghouse,5 so that these data can be pooled with those of other surveillance systems.
Methods
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In calculating the total number of previous siblings, the 14% of cases with unknown maternal parity were assigned the average parity of the centre concerned. A total prevalence rate was defined as the total number of cases in livebirths, stillbirths, and induced abortions after prenatal diagnosis of malformation, divided by the total number of births in the population.
The X2 test for homogeneity in proportions was used to test whether differences in total prevalence rates were significant between regions or over time and whether ratios (isolated to multiply malformed, or male to female) varied between regions. Centres too small to reach the requirement of an expected number of at least five cases in X2 analyses were excluded, and these exclusions can be seen by the number of degrees of freedom in the analysis. -----156  446 194  3-50  11  2-85  18  2-94  20  2-41  12  3-11  2  1-69  3  1-28  --147  544 178  2-70  11  2-82  18  4-36  10  1-78  6  1-52  5  2-53  11  2-35  5  3-10  139  556 517  2-50  38  3-24  50  3-06  62  2-78  24  2-61  7  2-22  14  1-99  5  3-10  442  1 Excluding chromosomal cases, and comparing all maternal age-specific rates with the 25-29 age group, there is a statistically significant increased risk only for the young mothers <20 years (odds ratio=1-82, 95% CI 1-23 to 2-67, MantelHaenszel odds ratio stratified by registry= 1 69, 95% CI 1 13 to 2-49).
A similar pattern of maternal age-specific risk is seen for both isolated and associated cases (table 3). The difference in odds ratios for young mothers was not statistically significant (X2=0 11, p>005).
TWINS
There were a total of 18 twins (4 1% of all cases, 95% CI 2-3 to 6-1%). Ten cases had an isolated malformation (5 0% of all isolated cases), and five were multiply malformed (2-5% of multiply malformed cases), but the difference between these proportions is not statistically significant.
Three twins had chromosomal anomalies (6-8% of all chromosomal cases). These proportions should be compared with the approximately 2 to 2-2% of births in the EUROCAT populations that are twins or multiple births.
One twin pair was concordant for TOFA and Down's syndrome. In this pair there was discordance for presence of a fistula. One monozygotic twin who was multiply malformed Other anomalies in siblings in the six centres were atresia of bile ducts (n= 1), vesicoureteric reflux (n= 1), unspecified renal anomaly (n= 1), unspecified congenital heart disease (n=2), congenital dislocation of hip (n= 1), transposition of great vessels (n= 1), and shortened femur (n= 1). A total of eight cases among 262 previous pregnancies gives a precurrence rate for other anomalies of 3-1%, not significantly higher than the general malformation rates in the six populations, ranging from 1-8 to 3-2%.7 In the remaining nine centres there were 112 previous pregnancies where information about siblings was recorded as known. There were no precurrences among these cases. Other anomalies in four siblings were: trisomy 21 (n= 1), anencephaly (n= 1), and unspecified (n=2).
Information about parents is routinely requested on case report forms, but no parents were reported to be affected by TOFA. and Groningen (100-0%) but lower in Glasgow (64-3%). For multiply malformed cases, survival was generally lower (51-7% in Dublin, 50-0% in Groningen, and 17-6% in Glasgow). In Malta, there were four isolated cases all surviving to 1 year, and a chromosomal case lost to follow up after livebirth.
BIRTH WEIGHT AND GESTATIONAL AGE

PRENATAL DIAGNOSIS AND INDUCED ABORTION
In four centres (Hainaut, Paris, Marseille, and Glasgow) 10 isolated cases were prenatally diagnosed where the outcome of pregnancy was a livebirth, 14 -5% of all isolated cases in these centres.
All 16 induced abortions after prenatal diagnosis were multiply malformed (n=9) or chromosomal (n=7) cases, from five centres (Groningen, Glasgow, Hainaut, Paris, and Marseille). A further 24 multiply malformed cases and six chromosomal cases were prenatally diagnosed where the outcome ofpregnancy was a livebirth or stillbirth in these five centres as well as Liverpool, Belfast, Strasbourg, Galway, and Dublin.
Discussion
The prevalence rate of TOFA reported here is similar in different regions of Europe, and is broadly similar to rates quoted in the literature from within and outside Europe2'3 I although a higher rate of4-1 per 10 000 has been reported in Finland. 4 The downward trend in prevalence over time, which requires further investigation, raises the possibility of an environmental factor that is 15 An analysis of different types of TOFA was limited in this series by the lack of detailed case description in most centres. As is generally observed, the vast majority ofcases had oesophageal atresia with tracheo-oesophageal fistula.
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The proportion of fistulas without atresia (over 9%) is higher than that reported in the literature."13 The higher proportion of multiply malformed cases among those with fistulas without atresia in this series might be to some extent explained by delayed detection of this anomaly when it is in an isolated form' 16 and therefore underascertainment of isolated cases. A higher rate ofTOFA could be demonstrated among younger mothers of less than 20 years of age. In an English study where maternal age was analysed,'3 both young (<20) and older (>35) mothers were shown to have an increased risk. The results of the present study suggest that any increase shown among older mothers is attributable to chromosomal abnormalities.
The precurrence rate among siblings estimated here (3/262) was greater than that reported in a previous study where only one in 340 previous siblings was affected by TOFA.'3 As familial cases seem to be rare, large series will be needed for analysis. The lack of concordant twins among non-chromosomal cases and the very low precurrence rate in siblings supports the importance of non-genetic factors in the aetiology of the anomaly.
No parents were found to be affected. Although there may have been cases where the anomaly in a parent was not reported, this suggests that survival of infants with TOFA to reproductive age since the introduction of effective surgery is not causing any unexpected increase in familial cases.
The higher than expected rate of twinning among TOFA cases suggests that twinning may predispose towards these malformations or that common aetiological factors are involved. Differences in the proportion of twins between isolated, multiply malformed, and chromosomal cases need confirmation in a larger data set before it is possible to speculate further on their significance.
Treatment of TOFA is generally successful and survival depends on the presence of other associated major anomalies. The apparently lower survival of both isolated and multiply malformed cases in Glasgow is being investigated by the local paediatric surgeons, who have expressed their concern at the findings. In a comparison between centres, stillbirths and very early postnatal deaths should be grouped together, but Glasgow continued with a low survival rate after 1 week of age.
Poor fetal growth and prematurity seem to be characteristics of TOFA, whether isolated or associated with other major malformations. As it cannot be said whether poor growth predisposes to, is a consequence of, or is simply associated with the malformation, it is not clear whether population measures preventing prematurity or fetal growth retardation will have any effect on the incidence of the malformation. The generally improving survival rates for very low birthweight infants may be expected to lead to a slight increase in TOFA prevalence among livebirths.
The higher than expected proportion of stillbirths among isolated cases points to a common cause ofreduced fetal survival and the malformation, a factor which may also be implicated in poor fetal growth. However, the possibility that fetal death was associated with undiagnosed internal malformations cannot be excluded.
TOFA constitutes an ideal subject for collaborative investigation, being relatively easily diagnosed and classified in a standard fashion, and recognised soon after birth. As enormous progress has been made in the treatment of this condition, the next significant development will come from aetiological research leading to primary prevention.
EUROCAT is a Concerted Action of the European Community.
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